Issue 5/2014
Content (10 Articles)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek, Radosław Zagożdżon, Marek Jakobisiak
ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
Giovanna Bossi, Sandrine Buisson, Joanne Oates, Bent K. Jakobsen, Namir J. Hassan
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, Rob R. H. van den Brom, Geke A. P. Hospers, Alfonsus J. M. van den Eertwegh, Ellen W. Kapiteijn, Jan Willem B. de Groot, Patricia Soetekouw, Rob L. Jansen, Edward Fiets, Andrew J. S. Furness, Alexandra Renn, Marcin Krzystanek, Zoltan Szallasi, Paul Lorigan, Martin E. Gore, Ton N. M. Schumacher, John B. A. G. Haanen, James M. G. Larkin, Christian U. Blank
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells
Shigeo Koido, Masaki Ito, Yukiko Sagawa, Masato Okamoto, Kazumi Hayashi, Eijiro Nagasaki, Shin Kan, Hideo Komita, Yuko Kamata, Sadamu Homma
Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
Takumi Kumai, Kei Ishibashi, Kensuke Oikawa, Yoshinari Matsuda, Naoko Aoki, Shoji Kimura, Satoshi Hayashi, Masahiro Kitada, Yasuaki Harabuchi, Esteban Celis, Hiroya Kobayashi
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma
Takeshi Terashima, Eishiro Mizukoshi, Kuniaki Arai, Tatsuya Yamashita, Mariko Yoshida, Hajime Ota, Ichiro Onishi, Masato Kayahara, Koushiro Ohtsubo, Takashi Kagaya, Masao Honda, Shuichi Kaneko
Alterations of costimulatory molecules and instructive cytokines expressed by dendritic cells in the microenvironment of an endogenous mouse lymphoma
Marcella Naujoks, Jakob Weiß, Tanja Riedel, Nadine Hömberg, Margarethe Przewoznik, Elfriede Noessner, Martin Röcken, Ralph Mocikat
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity
Valentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, Antonella Brizzolara, Laura Emionite, Daniela Fenoglio, Gilberto Filaci, Michela Croce, Silvano Ferrini
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt, Jonathan B. Mitchem, Lori A. Worley, Brian D. Goetz, Pinku Mukherjee, Andrea Wang-Gillam, Daniel C. Link, David G. DeNardo, S. Peter Goedegebuure, David C. Linehan
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013
Elisabetta Bolli, Laura Conti, Federica Riccardo, Cristina Marchini, Augusto Amici, Federica Cavallo, Elena Quaglino